I am pleased to announce that Julphar has closed the year 2014 at AED1.433 billion, producing overall steady results, with a year-on-year growth of 5.2% over sales from 2013.
Julphar is a proud Emirati Company with great ambitions to thrive in International markets and this remains at the heart of our business. A key priority is to identify opportunities which will create long-term value for our Shareholders and enable us to provide quality, affordable medicines to people now and in future generations.
I would like to congratulate the Julphar Executive team for their leadership abilities, producing sustainable returns and focusing on developing a skilled National work force through our Emiratisation Program and Absher initiative.
As the global Healthcare market continues to grow at a tremendous rate, we extend our thanks to the Government, our Customers, Employees, our well-wishers, Board of Directors and all other stakeholders for their wholehearted and continued support and contribution in the success of Julphar.
His Highness Sheikh Faisal Bin Saqr Al Qasimi